IRIS Accounts Production v26.1.0.640 09090390 Board of Directors 1.8.24 31.7.25 31.7.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh090903902024-07-31090903902025-07-31090903902024-08-012025-07-31090903902023-07-31090903902023-08-012024-07-31090903902024-07-3109090390ns15:EnglandWales2024-08-012025-07-3109090390ns14:PoundSterling2024-08-012025-07-3109090390ns10:Director12024-08-012025-07-3109090390ns10:PrivateLimitedCompanyLtd2024-08-012025-07-3109090390ns10:SmallEntities2024-08-012025-07-3109090390ns10:AuditExempt-NoAccountantsReport2024-08-012025-07-3109090390ns10:SmallCompaniesRegimeForDirectorsReport2024-08-012025-07-3109090390ns10:SmallCompaniesRegimeForAccounts2024-08-012025-07-3109090390ns10:AbridgedAccounts2024-08-012025-07-3109090390ns10:Director22024-08-012025-07-3109090390ns10:Director32024-08-012025-07-3109090390ns10:RegisteredOffice2024-08-012025-07-3109090390ns5:ShareCapital2025-07-3109090390ns5:ShareCapital2024-07-3109090390ns5:RetainedEarningsAccumulatedLosses2025-07-3109090390ns5:RetainedEarningsAccumulatedLosses2024-07-31
REGISTERED NUMBER: 09090390 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2025

FOR

TIKA DIAGNOSTICS LIMITED

TIKA DIAGNOSTICS LIMITED (REGISTERED NUMBER: 09090390)

CONTENTS OF THE FINANCIAL STATEMENTS
For The Year Ended 31 July 2025










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


TIKA DIAGNOSTICS LIMITED

COMPANY INFORMATION
For The Year Ended 31 July 2025







DIRECTORS: K Hilpert
T J Bull
M Cranmer





REGISTERED OFFICE: City St George's University of London
Mailbox J1B
Cranmer Terrace
London
SW17 0RE





REGISTERED NUMBER: 09090390 (England and Wales)

TIKA DIAGNOSTICS LIMITED (REGISTERED NUMBER: 09090390)

ABRIDGED BALANCE SHEET
31 July 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 10,556 13,195

CURRENT ASSETS
Debtors 803 668
Cash at bank 49,014 53,522
49,817 54,190
NET CURRENT ASSETS 49,817 54,190
TOTAL ASSETS LESS CURRENT
LIABILITIES

60,373

67,385

PROVISIONS FOR LIABILITIES 2,006 2,507
NET ASSETS 58,367 64,878

CAPITAL AND RESERVES
Called up share capital 10 10
Retained earnings 58,357 64,868
SHAREHOLDERS' FUNDS 58,367 64,878

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

TIKA DIAGNOSTICS LIMITED (REGISTERED NUMBER: 09090390)

ABRIDGED BALANCE SHEET - continued
31 July 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 July 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 April 2026 and were signed on its behalf by:





T J Bull - Director


TIKA DIAGNOSTICS LIMITED (REGISTERED NUMBER: 09090390)

NOTES TO THE FINANCIAL STATEMENTS
For The Year Ended 31 July 2025


1. STATUTORY INFORMATION

Tika Diagnostics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents income for services relating to the research into bacterial disease diagnostics, excluding value added tax, performed during the year.

Turnover is recognised as the right to consideration arises and adjustments are made for accrued and deferred income.

Tangible fixed assets
Tangible fixed assets are stated at cost or valuation less accumulated depreciation. Cost includes costs directly attributable to making the asset capable of operating as intended by management.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful
life.

Plant and machinery-20% on reducing balance

Financial instruments
The company enters into basic financial instruments, which result in the recognition of financial assets and liabilities. Financial instruments are recognised at amortised cost. At the end of each reporting period financial instruments are assessed for evidence of impairment, and changes are recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods.

Deferred tax represents the future tax consequences of material transactions and events recognised in the financial statements of current and previous periods.

Current and deferred tax assets and liabilities are not discounted and are recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

TIKA DIAGNOSTICS LIMITED (REGISTERED NUMBER: 09090390)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Year Ended 31 July 2025


4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 August 2024
and 31 July 2025 99,133
DEPRECIATION
At 1 August 2024 85,938
Charge for year 2,639
At 31 July 2025 88,577
NET BOOK VALUE
At 31 July 2025 10,556
At 31 July 2024 13,195